Tony Liu is a partner at Weiming Capital. He holds a Ph.D. in Genetics from Southeast University.

With over 10 years of senior management experience in multinational pharmaceutical companies, he formerly worked as a research scientist in vaccine and microecological preparations development at Beijing Hanmi and Sanofi Pasteur.

Prior to joining Weiming Capital, he served as the Managing Director and Partner of Shenzhen GIG Investment Group and Shenzhen Green Pine Capital Partners.

With years of experience in vaccine and innovatonal drug investment, he has led and participated in investments in companies such as Beijing Endi Biotec, Shanghai Immune-path Biotech, and Shenzhen Yuanxing Gene.